. Author manuscript; available in PMC: 2010 Sep 25.

Published in final edited form as: J Surg Oncol. 2009 Jul 1;100(1):25–31. doi: 10.1002/jso.21284

Table 3.

Treatment related characteristics

	No. of. Patients (%)
Re-excision
Yes	271 (61.7)
No	169 (38.5)
Final margin status
Negative	342 (77.9)
Close	49 (11.2)
Positive	13 (3)
LCIS only	6 (1.4)
Unknown	30 (7)
Radiotherapy
Total dose primary (median dose), tangents	5000 cGy (200–5040)
Boost , median dose-range	1000 (1000–1800)
Yes	420 (95.7)
No	20 (4.6)
Post Bx Mammogram
Yes	240 (54.7)
No	198 (45.1)
Unknown	2 (0.5)
Adjuvant treatment
Tamoxifen	96 (21.9)
No systemic therapy	342 (77.9)
Chemotherapy only	1 (0.2)
Chemotherapy/Tamoxifen	1 (0.2)

Abbreviations: cGy= Centi gray; LCIS= Lobular carcinoma in situ; Bx= Biopsy.